Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Biorxiv : the Preprint Server for Biology|April 22, 2024
PGC-1α drives small cell neuroendocrine cancer progression towards an ASCL1-expressing subtype with increased mitochondrial capacityGrigor Varuzhanyan, Chia-Chun Chen, Jack Freeland, et al.
Nature Communications|August 16, 2017
ATR inhibition facilitates targeting of leukemia dependence on convergent nucleotide biosynthetic pathwaysThuc M Le, Soumya Poddar, Joseph R Capri, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 26, 2024
PGC-1α drives small cell neuroendocrine cancer progression toward an ASCL1-expressing subtype with increased mitochondrial capacityGrigor Varuzhanyan, Chia-Chun Chen, Jack Freeland, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 23, 2022
<sup>18</sup>F-FDG PET Visualizes Systemic STING Agonist-Induced Lymphocyte Activation in Preclinical ModelsThuc M Le, Hailey R Lee, Evan R Abt, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2019
Lysosome inhibition sensitizes pancreatic cancer to replication stress by aspartate depletionIrmina A Elliott, Amanda M Dann, Shili Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 26, 2024
Staggered immunization with mRNA vaccines encoding SARS-CoV-2 polymerase or spike antigens broadens the T cell epitope repertoireEvan R Abt, Alex K Lam, Miyako Noguchi, et al.
Cell Reports|January 12, 2022
Reprogramming of nucleotide metabolism by interferon confers dependence on the replication stress response pathway in pancreatic cancer cellsEvan R Abt, Thuc M Le, Amanda M Dann, et al.
Nature Communications|January 31, 2026
Neoadjuvant modified FOLFIRINOX plus nivolumab in borderline-resectable pancreatic ductal adenocarcinoma: a pilot phase 1 trialZev A Wainberg, Jason M Link, Alykhan Premji, et al.
The Journal of Clinical Investigation|June 2, 2022
Purine nucleoside phosphorylase enables dual metabolic checkpoints that prevent T cell immunodeficiency and TLR7-associated autoimmunityEvan R Abt, Khalid Rashid, Thuc M Le, et al.
RSC Medicinal Chemistry|January 22, 2021
Isoquinoline thiosemicarbazone displays potent anticancer activity with <i>in vivo</i> efficacy against aggressive leukemiasDaniel L Sun, Soumya Poddar, Roy D Pan, et al.
Pageof 3